Remarkably, our studies on clinical specimens and data demonstrated that PKMYT1 expression was negatively associated with both overall survival (P = 0.01) and relapse-free survival (P = 0.03) in NSCLC patients [Fig. 6D and E]. This evidence concerns the gene PKMYT1 and non-small cell lung carcinoma.